Joerg R. Weber

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Lipoteichoic Acid (LTA) of Streptococcus pneumoniaeand Staphylococcus aureus Activates Immune Cells via Toll-like Receptor (TLR)-2, Lipopolysaccharide-binding Protein (LBP), and CD14, whereas TLR-4 and MD-2 Are Not Involved

Nicolas W.J. Schröder, Siegfried Morath, Christian Alexander et al. · Journal of Biological Chemistry · 2003 · 636 citations · Full text

Life Sciences, Biochemistry, Immunology +17

Pneumococcal pneumolysin and H2O2 mediate brain cell apoptosis during meningitis

Johann Braun, Jack Sublett, Dorette Freyer et al. · Journal of Clinical Investigation · 2002 · 310 citations · Full text

Life Sciences, Microbiology, Neuroscience +17

A Vicious Cycle Involving Release of Heat Shock Protein 60 from Injured Cells and Activation of Toll-Like Receptor 4 Mediates Neurodegeneration in the CNS

Seija Lehnardt, Eckart Schott, Thorsten Trimbuch et al. · Journal of Neuroscience · 2008 · 286 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia

Seija Lehnardt, Sabrina Lehmann, David Kaul et al. · Journal of Neuroimmunology · 2007 · 250 citations

Life Sciences, Neurology, Neuroscience +16